Priv. Doz. Dr. Stefan Stättner, FRCS(Eng), FEBS (HPB)

Leiter AG Leber/Galle/Pankreas

Univ. Klinik f. Viszeral-, Transpl.- u. Thoraxchirurgie
Med. Univ. Innsbruck

Anichstr. 35
6020 Innsbruck

Tel: +43-512-504
Email: s.staettner@icloud.com


Geb. 05.07.1976 in Wien
verheiratet, 3 Kinder

Beruflicher Werdegang

1994 – 2001  Medizinische Universität Wien
2001 – 2003  Turnusausbildung Allgemeinmedizin/Gegenfächer Chirurgie  
2003 – 2009  Assistenzarzt für Chirurgie (KFJ Spital Wien – Prim. Prof. J.Karner)
Facharzt für Chirurgie 1.1.2009  
04 – 09/2008  Universitätsklinik für Chirurgie, AKH Wien 
2009 – 2013 Hospitationen Leberchirurgie (Barcelona, Berlin, Paris, Leeds, Amsterdam) 
08/2011 – 7/2012  Fellowship, Aintree University Hospital, Liverpool UK (Prof. G. Poston) 
09/2012  Oberarzt Universitätsklinik für Chirurgie PMU  
04/2013  Leitender Oberarzt für Leber-, Gallenwegs- und Pankreaschirurgie PMU  
05/2013  Europäischer Facharzt (FEBS) für Leber- und Pankreaschirurgie  
11/2014 Habilitation PMU: “Erweiterung der Resektabilität primärer und sekundärer Lebertumore”
11/2014  Facharzt für Viszeralchirurgie 

Postgraduelle Diplome/Zusatzausbildung

2002   Diplom für Ernährungsmedizin 2002 
2002-2003 Akademischer Lehrgang in Tumorbiologie
(Krebsforschungsinstitut Wien)  
2005  Zertifizierter Wundmanager (ZWM Kammerlander) 2005 
2009  Diplom Klinischer Prüfarzt 
2010, 2012  DFP Fortbildungsdiplom 
2010  Medical Education – Medizinische Universität Wien 
2013  Medizinische Didaktik
2013-2014  Medizin und Management, PMU 

Wissenschaftliche Förderungen

Felix Mandl Fonds –
Wifo 87/2008 
Identification of Potentially New Therapeutic Targets in the Microenvironment of Hepatocellular Carcinoma (HCC)
10.000 € 
Medical Scientific Fund
of the Major
of the City of Vienna 10091
Expression of Telomeres as a therapeutic Target in Colorectal Cancer
47.200 €  
Salzburg Cancer
Aid Fonds 2013 
Radiofrequency Ablation vs. Microwave Ablation in a perfused pig liver – which method develops better thermal tissue conductance under guidance of an infrared camera?
6.307 € 
Salzburg Cancer
Aid Fonds 2014 
Microwave Ablation of Colorectal Cancer Liver Metastasis: Understanding the Mechanisms of early Cell Death and Local Recurrence through Correlation of Histochemical Markers and Clinical Patterns
7.000 € 
Salzburg Cancer
Aid Fonds 2015 
Analysis of miRNA-145, miRNA-145a and miRNA-30e in cholangiocellular carcinoma
7480 € 
Preise  Plenary Session ESSO 2012 Valencia
Wissenschaftspreis in Gold PMU 2013  

 Wissenschaftlicher Fokus

  • Kolorektales Karzinom
    – Telomerase (Univ.Prof.Dr.Klaus Holzmann)
    – Etablierung von liver endothelial cell Kulturen (PD Tanja Hartmann)
  • Mikrowellenablation kolorektaler Lebermetastasen
    CLIMB Study
  • Prädiktion postoperativer Leberdysfunktion
  • Pankreaskarzinom (Prof. Fritz Aberger, NAWI)
    Cancer Cluster Salzburg
  • Neuroendokrine Tumore des Pankreas (Prof. Daniel Neureiter, PD Tobias Kiesslich)

Publikationen

  1. „Interdisziplinäres Management von Lebermetastasen“
    Author in „Klinik“ – 4/04
  2. A novel technique to specifically analyze the secretome of cells and tissues
    Zwickl H., Traxler E., Staettner S., Parzefall W., Grasl-Kraupp B., Karner J., Schulte-Hermann R., Gerner C.
    Electrophoresis. 2005 Jul;26(14):2779-85.
  3. NORE 1B, a candidate tumor suppressor, is epigenetically silenced in human hepatocellular carcinoma.
    Macheiner D., Heller G., Kappel S., Bichler C., Stattner S., Ziegler B., Kandioler D., Wrba F., Schulte-Hermann R., Zochbauer-Muller S., Grasl-Kraupp B.
    J Hepatol.2006 Jul;45(1):81-9.
  4. Moderne Leberchirurgie – Standards in Diagnostik und Therapie.
    S.Stättner, T.Ybinger, B.Horvath-Mechtler, W.Appel, F.Karnel, M.Baur, C.Dittrich, M.Klimpfinger, F.Sellner, J.Karner
    Wiener Klinisches Magazin 2/2007
  5. FGF18 in colorectal tumour cells: autocrine and paracrine effects.
    Sonvilla G, Allerstorfer S, Stättner S, Karner J, Klimpfinger M, Fischer H, Grasl-Kraupp B, Holzmann K, Berger W, Wrba F, Marian B, Grusch M.
    Carcinogenesis. 2008 Jan;29(1):15-24.
  6. Well or poorly differentiated nonfunctioning neuroendocrine carcinoma of the pancreas: A single institution experience with 17 cases.
    F.Sellner, B.Sobhian, M.DeSantis, J.Pont, S.Staettner, S.Sellner, J.Karner, M.Klimpfinger
    Eur J Surg Oncol. 2008 Feb;34(2):191-5
  7. Abdominelle Sepsis und Kompartmentsyndrom – Management des offenen Abdomens
    S.Stättner, T.Wild, J.Karner
    Wiener Klinisches Magazin 6/2008
  8. Intermittent hepatic portal vein gas complicating diverticulitis – a case report and review of the literature.
    F.Sellner, B.Sobhian, M.Baur, S.Sellner, B.Horvath, M.Mostegel, J.Karner, S.Staettner
    Int J Colorectal Dis 2008 Nov;22(11):1395-9.
  9. Austrian Consensus on the surgical treatment of colorectal liver metastases.
    D.Öfner, T.Grünberger, W.Eisterer and expert panel
    Memo (2009)Vol.2:38-40
  10. Neuromuscular electrical stimulation reduces skeletal muscle protein degradation and stimulates insulin-like growth factors in an age- and current-dependent manner: a randomized, controlled clinical trial in major abdominal surgical patients.
    Strasser EM, Stättner S, Karner J, Klimpfinger M, Freynhofer M, Zaller V, Graf A, Wessner B, Bachl N, Roth E, Quittan M.
    Ann Surg. 2009 May;249(5):738-43.
  11. Management des Hepatozellulären Karzinoms
    S.Stättner, J.Karner, G.Haidinger, W.Mikulits, S.Meng, F.Karnel, F.Sellner, R.Pöhnl
    ACO-ASSO Manual 2009 (book chapter)
  12. Introducing the CPL/MUW proteome database: interpretation of human liver and liver cancer proteome profiles by referring to isolated primary cells.
    Wimmer H, Gundacker NC, Griss J, Haudek VJ, Stättner S, Mohr T, Zwickl H, Paulitschke V, Baron DM, Trittner W, Kubicek M, Bayer E, Slany A, Gerner C.
    Electrophoresis. 2009 Jun;30(12):2076-89.
  13. Chemoradiotherapy with 5-fluorouracil/leucovorin, surgery and adjuvant chemotherapy for locally advanced rectal cancer.
    M.Baur, M.Horvath, S.Stättner, A.Schratter-Sehn, B.Horvath, F.Sellner, M.Hudec, M.Klimpfinger, C.Dittrich, J.Karner
    Oncology Letters 1:189-194, 2010
  14. Association of IGF1 and IGFBP3 polymorphisms with colorectal polyps and colorectal cancer risk.
    Feik E, Baierl A, Hieger B, Führlinger G, Pentz A, Stättner S, Weiss W, Pulgram T, Leeb G, Mach K, Micksche M, Gsur A.
    Cancer Causes Control. 2010 Jan;21(1):91-7.
  15. Fibroblast growth factor receptor 3-IIIc mediates colorectal cancer growth and migration.
    Sonvilla G, Allerstorfer S, Heinzle C, Stättner S, Karner J, Klimpfinger M, Wrba F, Fischer H,  Gauglhofer C, Spiegl-Kreinecker S, Grasl-Kraupp B, Holzmann K, Grusch M, Berger W,    Marian B.
          Br J Cancer. 2010 Mar 30;102(7):1145-56.
  16. Up-regulation of the fibroblast growth factor 8 subfamily in human hepatocellular carcinoma for cell survival and neoangiogenesis.
    Gauglhofer C, Sagmeister S, Schrottmaier W, Fischer C, Rodgarkia-Dara C, Mohr T, Stättner  S, Bichler C, Kandioler D, Wrba F, Schulte-Hermann R, Holzmann K, Grusch M, Marian    B, Berger W, Grasl-Kraupp B.
    Hepatology. 2011 Mar;53(3):854-64. Epub 2011 Feb 11.
  17. TNM stage and grade in predicting the prognosis of operated, non-functioning neuroendocrine carcinoma of the pancreas-a single-institution experience.
    Sellner F, Thalhammer S, Stättner S, Karner J, Klimpfinger M.
    J Surg Oncol. 2011 Feb 24. doi: 10.1002/jso.21889
  18. Up-regulation of 12(S)-lipoxygenase induces a migratory phenotype in colorectal cancer cells.
    Klampfl T, Bogner E, Bednar W, Mager L, Massoudom D, Kalny I, Heinzle C, Berger W, Stättner S, Karner J, Klimpfinger M, Fürstenberger G, Krieg P, Marian B
    Exp Cell Res. 2012 Apr 1;318(6):768-78. Epub 2011 Dec 29
  19. Segmental and lobar administration of drug-eluting beads delivering irinotecan leads to tumour destruction: a case-control series.
    Jones RP, Dunne D, Sutton P, Malik HZ, Fenwick SW, Terlizzo M, O’Grady E, Koelblinger C, Stättner S, Stremitzer S, Gruenberger T, Poston GJ.
    HPB (Oxford). 2013 Jan;15(1):71-7.
  20. Uterine sliding sign – a simple sonographic predictor for presence of deep infiltrating endometriosis of the rectum.
    G.Hudelist, N.Fritzer, S.Staettner, A.Tammaa, A.Tinelli, R.Sparic, J.Keckstein
    Ultrasound Obstet Gynecol 2013 Feb 8
  21. Microwave ablation with and without resection of colorectal liver metastases.
    S.Stättner,Jones RP, Yip VS, Buchanan K, Poston GJ, Malik HZ, Fenwick SW.
    Eur J Surg Oncol. 2013 Jun 13.
  22. Liver resection with concomitant inferior vena cava resection – experiences without Veno-Venous Bypass
    S.Stättner Yip V, Jones RP, Lacasia C, Fenwick SW, Poston GJ, Malik H.
    Surg Today. 2013 Jun 26.
  23. Radiological assessment of response to neoadjuvant transcatheter hepatic therapy with irinotecan-eluting beads (DEBIRI_) for colorectal liver metastases does not predict tumour destruction or long-term outcome
    Jones RP*, Stättner S*, Dunne DF, O’Grady E, Smethurst A, Terlizzo M, Malik HZ, Fenwick        SW, Poston GJ. – *contributed equally
    Eur J Surg Oncol. 2013 Aug 5.
  24. Myofibroblasts are important contributors to human hepatocellular carcinoma: Evidence for tumor promotion by proteome profiling
    Slany A, Haudek-Prinz V, Zwickl H, Stättner S, Grasl-Kraupp B, Gerner C.
    Electrophoresis. 2013 Oct 1
  25. Tumour size and differentiation predict survival after liver resection for hepatocellular carcinoma arising from non-cirrhotic and non-fibrotic liver: A case-controlled study
    Yip VS, Gomez D, Tan CY, Staettner S, Terlizzo M, Fenwick S, Malik HZ, Ghaneh P, Poston G.
    Int J Surg. 2013 Oct 12.
  26. Female gender may predict response to FOLFIRINOX in patients with unresectable pancreatic cancer: A single institution retrospective review.
    Hohla F, Hopfinger G, Romeder F, Rinnerthaler G, Bezan A, Stättner S, Hauser-Kronberger C, Ulmer H, Greil R.
    Int J Oncol. 2014 Jan;44(1):319-26.
  27. Controversies in the oncosurgical management of liver limited stage IV colorectal cancer
    R.P. Jones, S. Stättner, P. Sutton, D.F. Dunne, D. McWhirter, S.W. Fenwick, H.Z. Malik, G.J. Poston
    Surg Oncol. 2014 Jun;23(2):53-60
  28. Evolution of surgical microwave ablation fort the treatment of colorectal cancer liver metastasis: single center experience and review of the literatur  
    S.Stättner
    , F.Primavesi, V.Yip, R.P.Jones, D.Öfner, H.Malik. S.Fenwick, G.J.Poston
    Surg Today. 2014 Mar 16. [Epub ahead of print], DOI:10.1007/s00595-014-0879-3.
  29. Small mesenteric hematoma following blunt abdominal trauma as early sign in computed tomography of occult small bowel perforation-report of 2 cases
    MW.Meissnitzer, S.Stättner, T.Meissnitzer
    Emerg Radiol. 2014 Dec;21(6):647-50
  30. Combined Ablation and Resection (CARe) as an Effective Parenchymal Sparing Treatment for Extensive Colorectal Liver Metastases
    Evrard S, Poston G, Kissmeyer-Nielsen P, Diallo A, Desolneux G, Brouste V, Lalet C, Mortensen F,  Stättner S, Fenwick S, Malik H, Konstantinidis I, DeMatteo R, D’Angelica M, Allen P, Jarnagin W, Mathoulin-Pelissier S, Fong Y.
    PLoS One. 2014 Dec8;9(12)

Mitgliedschaften

  • ÖGC – Österreichische Gesellschaft für Chirurgie
  • ACO-ASSO – Österreichische Gesellschaft für chirurgische Onkologie
  • BÖC – Berufsverband österreichischer Chirurgen
  • ESSO – European Society of Surgical Oncology
  • ÖGGH – Österreichische Gesellschaft für Gastroenterologie und Hepatologie
  • AKE – Arbeitsgemeinschaft für klinische Ernährung
  • IHPBA – International Hepato – Pancreato – Biliary Association
  • AUGIS – Association of Upper and Gastrointestinal Surgeons, UK
  • AGMT – Arbeitsgemeinschaft Medikamentöse Tumortherapie
  • ENETS – European Neuroendocrine Tumour Society
  • FRCS – Fellow of the Royal College of Surgeons of England
  • ANETS – Österreichische Neuroendokrine Tumorgesellschaft